C. Leschke

Papers

1

Total Citations

10

H-Index

1

About

Dr. C. Leschke is a pioneering researcher in regenerative medicine and biomanufacturing, with a focus on scalable, automated systems for cell therapy production. Their most notable contribution is the development of the AUTOSTEM platform, a closed, robotic system for manufacturing bone marrow-derived mesenchymal stromal cells (MSCs). This work, published in 2017 and cited 10 times, addresses a critical bottleneck in cell therapy: the transition from lab-scale to clinical-grade production. By enabling automated, closed-system culture, Leschke’s platform reduces contamination risk and enhances reproducibility, directly supporting the translation of MSC therapies for immune modulation and tissue repair. Their research bridges engineering and biology, offering a practical solution for scalable cell manufacturing. Leschke’s work is foundational for researchers seeking to industrialize cell therapies, and their platform has been recognized as a key step toward affordable, accessible treatments. With a focus on process optimization and quality control, Leschke continues to shape the future of regenerative medicine.

Research Focus

Key Achievements

1
H-Index
1
Papers
10
Total Citations
10
Avg Citations/Paper
🏆 Most Cited Paper
The AUTOSTEM platform for closed manufacture of bone marrow-derived mesenchymal stromal cells using a closed, scalable and automated robotic system
10 citations · 2017
📈 Most Prolific Year: 2017 (1 Papers)
🤝 Key Collaborators: 10

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 10 days ago